Eli Lilly: JPMorgan Raises Target Price To $1,400 From $1,300
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.